A carregar...
HOTAIR‐EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma
BACKGROUND: Glioblastoma (GBM) is the most common primary tumor in the brain, and the median survival time for GBM patients is only about 14 months; therefore, there is an urgent need for new and more effective strategies. Since cell cycle disorder is a key factor in tumor progression and immortaliz...
Na minha lista:
| Publicado no: | Clin Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7240863/ https://ncbi.nlm.nih.gov/pubmed/32508030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ctm2.21 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|